Synaptic Density and Progression of Parkinson's Disease.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 28, 2022

Study Completion Date

February 28, 2022

Conditions

Parkinson Disease

Interventions

OTHER

11C-UCB-J PET-CT

Positron Emission Tomography (PET) of synaptic vesicle protein 2A (SV2A) using the radioligand 11C-UCB-J.

OTHER

18F-PE2I PET-MR

Positron Emission Tomography (PET) of dopamine transporter (DAT) using the radioligand 18F-FE-PE2I, and brain MRI performed simultaneously.

Trial Locations (1)

UZ Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04243304 - Synaptic Density and Progression of Parkinson's Disease. | Biotech Hunter | Biotech Hunter